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Hypochlorous acid (HOCl), as a highly potent oxidant, is well known as a key “killer” for pathogens in 
innate immune system. Recently, mounting evidence indicates that intracellular HOCl plays additional 
important roles in regulating inflammation and cellular apoptosis. However, the organelle(s) involved in 
the distribution of HOCl remain unknown, causing difficulty to fully exploit its biological functions in 
cellular signaling pathways and various diseases. One of the main reasons lies in the lack of effective 
chemical tools to directly detect HOCl at sub-cellular levels due to low concentration, strong oxidization 
and short lifetime of HOCl. Herein, the first two-photon fluorescent HOCl probe (TP-HOCl 1) and its 
mitochondria- (MITO-TP) and lysosome- (LYSO-TP) targetable derivatives for imaging mitochondri-
al and lysosomal HOCl were reported. These probes exhibit fast response (within seconds), good selec-
tivity and high sensitivity (< 20 nM) toward HOCl. In live cell experiments, both mitochondria- 
(MITO-TP) and lysosome- (LYSO-TP) targetable probes were successfully applied to detect intracel-
lular HOCl in corresponding organelles. In particular, the two-photon imaging of MITO-TP and 
LYSO-TP in murine model shows that both higher amount of HOCl can be detected in lysosome and 
mitochondria of macrophage cells during inflammation condition. Thus, these probes could not only 
help clarify the distribution of sub-cellular HOCl, but also serve as excellent tools to exploit and eluci-












The study of reactive oxygen species (ROS) is attracting increasing attention due to their essential roles 
in cell signaling and homeostasis, such as aging,1 pathogen response,2 anti-inflammation regulation.3 
Among various ROS, hypochlorous acid (HOCl) as a highly potent oxidant generated during phagocy-
tosis, seems to mainly serve as a “killer” for pathogens in innate immune system.4 It is usually produced 
by myeloperoxidase (MPO)-catalyzed per-oxidation of chloride ions in phagolysosome, where patho-
gens are engulfed and decomposed5 (Figure 1). In addition to phagosomal HOCl in the presence of 
pathogens, mounting evidence demonstrates that nonphagosomal intracellular HOCl (nphHOCl) genera-
tion can be induced by a variety of soluble stimuli,6,7 which helps suppress inflammation and regulate 
cellular apoptosis.8,9 Furthermore, it is reported that nphHOCl may also be implicated in neurodegenera-
tive disorders10 such as Parkinson’s disease11 and cerebral ischemia.12 At the same time, HOCl could 
cause mitochondrial permeabilisation,13 lysosomal rupture14 and cell death through calcium dependent 
calpain activation.13 However, the distribution of nphHOCl at sub-cellular levels is still unclear, which 
causes severe difficulty 
 
Figure 1. Stimuli that induce intracellular HOCl. Apart from ingested particles that give rise to phago-
somal HOCl (phHOCl) production (left), certain stimuli, such as LPS, lead to nonphagosomal HOCl 
(nphROS) production without being ingested (right). H2O2, hydrogen peroxide; MPO, myeloperoxidase.  
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to fully exploit and elucidate intracellular functions of nphHOCl.15 One of the main reasons lies in lack 
of efficient tools to directly real-time monitor nphHOCl at sub-cellular level due to its strong oxidiza-
tion,16 short-lived time17 and relatively low concentration.18 Therefore, it is challenging and highly de-
sired to prepare novel chemical tools for elucidating the distribution and functions of nphHOCl at sub-
cellular level. 
Fluorescence imaging possesses unique advantages for the observation of functional and molecular 
recognition events in live cells.19,20 Furthermore, it has emerged as the irreplaceable technique to moni-
tor the level, localization, and movement of bio-molecules at sub-cellular levels.21-25 Among various 
types of optical imaging techniques, two-photon microscopy (TPM) offers a high-resolution imaging, 
deep penetration and low photo-toxicity due to the remarkably focused excitation and reduced scattering 
of near-infrared light in biological tissues.26-29  Recently, the detection of HOCl was implemented by 
some good probes with different recognition moieties, including dibenzoylhydrazine,30 p-
methoxyphenol,31,32 oxime,33-36 selenide,37-40 thiol compounds (internal thioester41-44, thioether45,46,6,72 
and thiosemicarbazide48) and other groups,47,49,64 which were specified in Table S1.  Even most of these 
probes have been successfully applied to image intracellular HOCl, few probes were used to real-time 
detect HOCl at sub-cellular levels. On the other hand, it was assumed that nphHOCl may be generated 
in both mitochondria and lysosome of macrophage cells due to the intracellular distribution of MPO that 
catalyzes HOCl production.50,51 Nevertheless, to the best of our knowledge, except for several mito-
chondria-located fluorescent probes for the detection of intracellular HOCl,46,52,73, there is no report yet 
describing a fluorescent probe for successful detection of intracellular HOCl in lysosome, even there 
were two reported lysosome targeting probes with exogenously added HOCl. 40,53 The aforementioned 
concerns encouraged us to develop novel two-photon fluorescent probes to sense this important bio-
molecule and clarify its distribution in live cell and inflamed mouse model. 
Herein, we report the first two-photon fluorescent “turn-on” HOCl probe (TP-HOCl 1) and its mi-
tochondria- (MITO-TP) and lysosome- (LYSO-TP) targetable derivatives, which can image intracellu-
lar HOCl in live cell and inflamed mouse model. In the presence of HOCl, TP-HOCl 1 exhibits a dra-
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matic fluorescence increase with very short response time (within seconds), excellent selectivity and 
high sensitivity (16.6 nM). Besides, in live cell experiments, it is clearly indicated that MITO-TP and 
LYSO-TP can respond towards HOCl in mitochondria and lysosome. Furthermore, these probes were 
successfully applied to image mitochondrial and lysosomal HOCl in inflamed mouse model through 
two-photon imaging.   
 
RESULTS AND DISCUSSION 
Design and synthesis of HOCl probes. Acedan, as a well-known two-photon fluorophore,54-57 was 
chosen as the fluorescence reporting group due to its excellent photo-physical properties resulting from 
the typical “push-pull” (amine-ketone) structure (scheme 1A).57 Thus, it is predictable that protection of 
the ketone will decrease the “pull” ability thereby quenching the fluorescence of Acedan. On the other 
hand, it is reported that thiol atom in methionine is easily oxidized in tandem to sulfoxide and sulphone 
by HOCl.58 Thus, 2-mercaptoethanol and 1, 2-ethanedithiol were employed to protect the ketone of ace-
dan in the design of HOCl probes (TP-HOCl 1 and TP-HOCl 2). It was expected that both compounds 
will be non-fluorescent or weakly fluorescent due to the disruption of the “push-pull” structure; however, 
reaction with HOCl, which de-protects the oxathiolane/mercaptal group to reveal the ketone, would lead 
to fluorescence enhancement. This expectation was further supported by the significantly increased os-
cillator strength of TP-HOCl 1 (ƒ, from 0.067 to 0.44) before and after reacting with HOCl calculated 
by density functional theory (DFT) (Figure S1). For comparison, oxime, a known reaction site for 
HOCl,33, 34, 36, 59 was also introduced by combining hydroxylamine with acedan (TP-HOCl 3). Through 
comparison of response ability of three probes to HOCl, TP-HOCl 1 was chosen as ideal HOCl probe, 
which was specified in the following paragraphs.  
To monitor HOCl at sub-cellular levels, lysosome- and mitochondria- targetable groups (morpho-
line60 and triphenylphosphine61) were further introduced to ensure the probe’s intracellular localization. 
In addition, to avoid affecting the sensitivity of the probe, these groups were carefully positioned at the 
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other end of acedan to generate long distance gap from the reaction site. The lysosomal HOCl probe 
Lyso-TP and mitochondrial HOCl probe Mito-TP were effectively prepared from cyclization reaction 
of precursor 4 or 7 with 2-mercaptoethanol (Scheme 1E). The precursor 4 was synthesized through the 
hydrolysis of commercially available dye 6-methoxy-2-acetonaphthone and subsequent amination of 
intermediate 3 with 4-(2-aminoethyl)morpholine. The precursor 7 was readily synthesized  
 
Scheme 1. The synthesis and proposed sensing mechanism of probes for HOCl. Reagents and condi-
tions: a) 2-mercaptoethanol, 50 ˚C, 3 h. b) 1,2-ethanedithiol, 50 ˚C, 3 h. c) hydroxylamine, 50 ˚C, 3 h.  
d) 37% HCl, reflux, 48 h. e) 2-morpholinoethanamine, Na2S2O5, microwave  80 W, 160 ˚C, 5 h. f) pro-
pane-1,3-diamine, Na2S2O5, microwave  80 W, 160 ˚C, 6 h. g) 2-bromoacetyl chloride, r.t., 50 min. h) 




through amination of intermediate 3 with 1, 3-propanediamine, and then amide coupling with 2-
bromoacetyl chloride, and finally salt formation with triphenylphosphine. The detailed synthetic proce-
dures, NMR and HRMS spectra were displayed in supporting information. 
Comparing the fluorescent response of TP-HOCl 1-3 to HOCl. To compare the fluorescent response 
of TP-HOCl 1-3 to HOCl, three probes were titrated with HOCl from 0 to 75 μM. Compared to TP-
HOCl 2, the fluorescence intensity ratio (F/F0 at 500 nm) of TP-HOCl 1 was enhanced more signifi-
cantly at low concentration of HOCl (Figure 2A) thereby indicating higher sensitivity. One reason may 
be due to the single sulfur atom in 1, 3-oxathiolane, which would require less HOCl for complete oxidi-
zation of TP-HOCl 1. Different from TP-HOCl 1 and TP-HOCl 2, oxime-based probe TP-HOCl 3 
shows only slight response to HOCl, which may be attributed to the more effective oxidative de-
protection of oxime by HOCl under basic condition.33 Therefore, TP-HOCl 1 was chosen as the probe 
for HOCl detection and its basic photo-physical properties were examined (Table S2 and Figure S2).  
Fluorescent response of TP-HOCl 1 to HOCl. To investigate the sensitivity, selectivity and response 
time of TP-HOCl 1 to HOCl, fluorescence spectroscopy was measured at various concentrations of 
HOCl. As it is shown in Figure 2B, the fluorescence intensity of TP-HOCl 1 at 500 nm increased more 
than 670 fold when 20 equivalents of HOCl was added, which results from the recovery of “push-pull” 
structure of acedan when the oxathiolane was de-protected by HOCl. Moreover, TP-HOCl 1 could re-
spond to low concentration of HOCl with detection limit up to 16.6 nM (Figure S3), which indicates the 
high sensitivity of probe TP-HOCl 1 to HOCl and the ability of probe TP-HOCl 1 to monitor trace 
amounts of intracellular HOCl. In addition, the time dependent fluorescence intensity changes of probe 




Figure 2. Fluorescence spectra of TP-HOCl 1-3 responding to HOCl in PBS/EtOH (1:1, pH 7.4) solu-
tion. A) Plot of fluorescence intensity ratio (F/F0 at 500 nm) changes of TP-HOCl 1-3 as a function of 
HOCl concentrations, data acquired at 20 seconds after addition of HOCl (λex = 375 nm). B) Fluores-
cence enhancement of TP-HOCl 1 (5 μM) as a function of HOCl (0 to 100 μM). Inset shows Fluores-
cence spectra of TP-HOCl 1 (0.5 μM) before and after adding HOCl at low concentrations (0 to 200 
nM). C) The time course of fluorescence intensity of TP-HOCl 1 before and after adding 10 μM and 30 
μM of HOCl. D) Fluorescence responses of TP-HOCl 1 (5 μM) towards various analytes (50 μM for 
biomolecules (1-9) and 100 μM for other ROS/RNS (10-17)). 1) PBS; 2) ATP; 3) ADP; 4) NAD; 5) 
GSH; 6) Cys; 7) Fe3+; 8) Zn2+; 9) Cu2+; 10) H2O2; 11) •OH; 12) t-BuOOH; 13) t-BuOO•; 14) NO•; 15) 
O2
-; 16) ONOO-; 17) HOCl.  
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(pH 5.5, 7.4, 9.2) and the fluorescent signals remained nearly unchanged over time (Figure 2C and S4), 
which enables its real-time detection of HOCl. However, no fluorescence change was observed when 
TP-HOCl 1 was incubated with other ROS (50 μM) and bio-molecules (100 μM) (Figure 2D).  In addi-
tion, selectivity (HOCl 50 μM and other ROS 250 μM) was further examined at pH 5.5 and 7.8, which 
were chosen to mimic the lysosomal and mitochondrial pH respectively. As shown in Figure S5, TP-
HOCl 1 can also respond to HOCl rather than other ROS in both weak acid and basic environment. No-
tably, H2O2, a precursor of HOCl, does not interfere with the detection of HOCl even at 500 μM (Figure 
S6). In addition, TP-HOCl 1 displayed almost no response to another highly potent oxidant, peroxyni-
trite (ONOO-) (Figure S7), in good agreement with previous reported probes with thioester41-44 and thi-
oether45,46,6,39 as recognition moieties. TP-HOCl 1 is thus a good HOCl probe with high sensitivity, re-
markable selectivity and very short response time. 
Effect of pH to response ability and stability of TP-HOCl 1. To test the feasibility of TP-HOCl 1 as 
HOCl probe, the performance of TP-HOCl 1 to HOCl in PBS buffers with different pH values ranging 
from 4 to 9 was tested. As shown in Figure S8, after addition of HOCl, remarkable fluorescence en-
hancement of TP-HOCl 1 could be observed immediately at wide pH ranges (pH 4 to 9) without signif-
icant variances, indicating that the assay is compatible with most intracellular pH environments. Even it 
was reported that pH may affect the oxidizing rate of hypochlorite,62 it was difficult to discriminate the 
difference under various pH conditions because of the fast response of thioehter to hypochlorite, which 
can be achieved within seconds. Similar results can also be observed in the previous thioether-based 
probes.45,63 Meanwhile, a stability test for TP-HOCl 1 in PBS buffer was also conducted to check 
whether the oxathiolane group of TP-HOCl 1 is stable at intracellular pH values (pH 4 to 9). As indi-
cated by Figure 3A, almost no fluorescence changes were observed even after 4 hour incubation, while 
strong fluorescence was recovered after addition of 40 μM HOCl, which suggests the stability of TP-
HOCl 1. Therefore, these results clearly demonstrate the feasibility of TP-HOCl 1 responding towards 




Figure 3. A) Probe TP-HOCl 1 (5 μM) could kept stable in physiological pHs (pH 4-8). Probe was in-
cubated in various pH buffers (pH 4-9) for 0.5, 2, 4 h respectively, and then 40 μM HOCl was added. B) 
Fluorescence responses of TP-HOCl 1 towards HOCl generated in MPO/H2O2/Cl
- system (PBS, 20 μM 
H2O2, 1 U/mL MPO, pH=7.4, 37 ˚C). ABH (4-Aminobenzoic acid hydrazide, 10 μM) or Cys (cysteine, 
200 μM) was added at 1 and 2 min respectively. MPO: Myeloperoxidase; ABH: MPO inhibitor. 
Fluorescent response of TP-HOCl 1 to HOCl generated in Myeloperoxidase (MPO)/H2O2/Cl- sys-
tem. With the favorable features of TP-HOCl 1 demonstrated, the feasibility of real-time detection of 
HOCl generation in an enzyme system was further investigated. MPO/H2O2/Cl
- system (PBS, 20 μM 
H2O2, 1 U/mL MPO, pH=7.4, 37 ˚C) was used to mimic the generation of HOCl inside cells. As shown 
in Figure 3B, the fluorescence intensity of TP-HOCl 1 was increased immediately after addition into 
MPO/H2O2/Cl
- system. Continuous fluorescence increase over time was observed (within 15 min) due 
to gradual production of HOCl. Nevertheless, almost no variation in the fluorescent signals was ob-
served in the presence of only MPO or H2O2, which demonstrated that HOCl rather than H2O2 or MPO 
is the target analyte. Furthermore, there is no obvious signal increase after inhibition of MPO by addi-
tion of 4-aminobenzoic acid (ABH, an MPO inhibitor) into the MPO/H2O2/Cl
- system. Importantly, after 
addition of ABH or cysteine at 1 and 2 min, the increasing fluorescence intensity was inhibited immedi-
ately thereby showing plane lines. Taken all together, TP-HOCl 1 was successfully used in real-time 
  
11 
detection of HOCl generation in MPO/H2O2/Cl
- system, enabling itself to be a promising probe for 
studying HOCl-related biological processes. 
Mechanism of TP-HOCl 1 responding to HOCl. To further examine the sensing mechanism of probe 
TP-HOCl 1, reversed-phased HPLC-MS was used to clarify the process of the reaction between TP-
HOCl 1 and HOCl. The HPLC chromatograms of TP-HOCl 1 and compound 1 were shown in Figure 
S9A and D. After incubation with HOCl (100 μM and 200 μM) for 1 min (Figure S9C, D), except the 
peaks from TP-HOCl 1 and de-protected compound 1, a new peak with longer retention time was ob-
served. This compound was purified and identified as the chlorinated product (compound 9) through 1H 
NMR, 13C NMR and HRMS (Figure S10A-C). Meanwhile, the position of chlorine atom was further 
verified by H-H COSY, indicating that chlorine atom locates at C-7 rather than C-5 (Figure S10D).  A 
similar chlorination reaction with HOCl was also observed in other fluorophores, such as Si-fluorescein 
and rhodamine.43,64 In particular, the photo-properties of compound 9, such as quantum yield and two-
photon cross section, were measured, which suggests comparability with that of compound 1 (Table S2) 
thereby demonstrating little interference for further experiment. Taken together, a possible sensing 
mechanism of probe TP-HOCl 1 to HOCl is proposed and shown in Figure 4. Non-fluorescent TP-
HOCl 1 is initially oxidized by HOCl to intermediate sulfoxide compound 8, further oxidized to unsta-
ble sulphone and finally hydrolyzed to generate fluorescent compound 1. Then compound 1 was partial-
ly chlorinated to compound 9 by excessive HOCl. In addition, to verify the above sensing mechanism, 
intermediate sulfoxide compound 8 was also prepared. Notably, compared with TP-HOCl 1, unstable 
compound 8 is more easily oxidized to compound 1 by HOCl (Figure S11), suggesting that sulfoxide 




Figure 4. Proposed sensing mechanism of TP-HOCl 1 for HOCl.  
 
Fluorescence imaging of HOCl at sub-cellular level. HOCl, as the key “killer” for pathogens during 
phagocytosis, is proposed to be mainly produced from MPO-catalyzed peroxidation of chloride ions in 
phagolysosomes. Recently, accumulating research demonstrates that nonphagasomal HOCl (nphHOCl) 
can also be produced after incubation with soluble stimuli.52,65 However, the organelles with intracellu-
lar nphHOCl are still unclear, which limits further elucidation of the corresponding functions of 
nphHOCl at sub-cellular level. Therefore, to clarify the distribution of HOCl at sub-cellular levels, mi-
tochondria- (MITO-TP) and lysosome- (LYSO-TP) targetable derivatives of probe TP-HOCl 1 were 
synthesized through introducing triphenylphosphine61 or morpholine60 to the amine group. Furthermore, 
in vitro experiment demonstrates that both MITO-TP and LYSO-TP can respond to HOCl at nanomo-
lar level in PBS (1% DMSO, pH 7.4 and 5.0), respectively (Figure S12).  
As shown in Figure S13, cell cytotoxicity of the probes was initially examined in HeLa cells, which 
proves that there is no significant cytotoxicity in the presence of 1–32 µM probe MITO-TP or LYSO-
TP for 12 h. To determine the intracellular location of MITO-TP and LYSO-TP inside cells, the probe 
MITO-TP (or LYSO-TP) and Mito-Tracker Red (or Lyso-Tracker Red) were co-incubated with live 
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HeLa cells, which was treated HOCl (50 μM) for another 5 min. As expected, probe MITO-TP mainly 
localized in the mitochondria rather than lysosome and nucleus (Figure 5A and S14A), while LYSO-TP 
mainly stained in the lysosome of live cells (Figure 5B and S14B). Meanwhile, the same sub-cellular 
distribution of MITO-TP and LYSO-TP can also be confirmed in LPS/IFN-γ-stimulated macrophage 
 
Figure 5. Intracellular localization of MITO-TP and LYSO-TP in HeLa (A, B) and macrophages cells 
(C, D). A, B) images of HeLa cells pre-treated with 10 μM MITO-TP (or 10 μM LYSO-TP) for 20 
min and subsequently 1 μM Mito-Tracker Red (or 1 μM Lyso-Tracker Red) for 10 min. Then 50 μM 
HOCl was treated for another 5 min. C, D) images of macrophage cells pre-treated with LPS (120 ng / 
mL) / IFN-γ (20 ng / mL) for 24 h, then treated with 10 μM MITO-TP (or 10 μM LYSO-TP) for 20 
min and subsequently 1 μM Mito-Tracker Red (or 1 μM Lyso-Tracker Red) for another 10 min. Green: 




cells (Figure 5C, D and S15). After confirming the intracellular localization of LYSO-TP and MITO-
TP, the distribution time of these probes were evaluated in RAW cells  (shown in Figure S16). To effi-
ciently track the probes in cells, compound 4 and 7, the bright fluorescent precursors of LYSO-TP and 
MITO-TP were used to examine the intracellular distribution time. As shown in Figure S16, the fluo-
rescent intensity of compound 4 and 7 rapidly reaches the equilibrium state within 20 minutes in RAW 
cells and keeps stable in at least 60 min. Based on the structural similarity of probes (LYSO-TP and 
MITO-TP) and their precursors (4 and 7), it is rational to assume that the probes LYSO-TP and 
MITO-TP can also quickly reach the equilibrium state inside cells and keep stable for some time.  
     After that, the detection of HOCl in mitochondria and lysosome was examined in murine live macro-
phage cell line RAW 264.7 (Figure 6). It was reported that targeting groups such as 
triphenylphosphine66 and morpholine67,68 can significantly increase the distribution in mitochondria and 
lysosome respectively and relatively difficult to be washed out. Thus, RAW cells were incubated with 
MITO-TP and LYSO-TP for 20 min respectively and subsequently washed with PBS buffer to remove 
the free probes, which ensures that probes mainly localized in the targeted organelles (mitochondria and 
lysosome). As shown in Figure 6A (a, e), both MITO-TP and LYSO-TP stained cells showed very 
weak fluorescence. However, the intracellular fluorescence from both MITO-TP and LYSO-TP stained 
cells were much stronger when the cell was subsequently stimulated with Lipopolysaccharides (LPS, 1 
μg/mL) and Phorbol Myristate Acetate (PMA, 1 μg/mL) together (Figure 6A (b, f) and Figure 6B-C). 
Based on remarkable fluorescence increase from the probe localized organelles, it is evident that the in-
creased fluorescence signal is mainly due to the reaction between probes and non-phagosomal HOCl in 
mitochondria and lysosome.65 To further examine the above assumption, control experiments were per-
formed, in which 4-aminobenzoic acid hydrazide (ABH) was added to decrease cellular HOCl level 





Figure 6. Detection of HOCl in live RAW 264.7 macrophage cells via MITO-TP and LYSO-TP. A) 
Representative fluorescent images of macrophage cells. a, e) MITO-TP or LYSO-TP (15 μM) was in-
cubated with macrophages cells for 20 min and washed by PBS buffer. b, f) Cells were pre-incubated 
with probes, washed by PBS buffer and stimulated with LPS (1 μg/mL) / PMA (1 μg/mL) for 1 h. c, g)  
Cells were pre-incubated with probes, washed by PBS buffer and stimulated with LPS (1 μg/mL) / PMA 
(1 μg/mL) and ABH (200 μM) for 1 h . d, h) Cells were pre-incubated with probes, washed by PBS 
buffer and stimulated with LPS (1 μg/mL) / PMA (1 μg/mL) and NAC (1 mM) for 1 h. B, C) 
Quantiﬁcation of the ﬂuorescence signals from a-h. Data were normalized to the fluorescence intensity 
from LPS/PMA stimulated macrophage cells (b or f). Error bars are ± SD. n = 3. Scale bar: 30 μm.  
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and LYSO-TP stained cells is suppressed to some extent when the stimulated RAW cells were incubat-
ed with 200 μM ABH together. Similar phenomena were also observed in 24 h incubation of stimuli and 
ABH (Figure S17).  In addition, the fluorescence of probes stained cells can also be reduced clearly by 
addition of N-acetylcysteine (NAC), a powerful ROS scavenger71 (Figure 6A (d, h) and Figure 6B-C). 
This is mainly because most of the intracellular HOCl can be effectively removed by NAC, in which 
thiol atom can react with HOCl rapidly.  One possible reason for the existence of intracellular HOCl in 
both mitochondrial and lysosomal is the movement of intracellular HOCl between organelles. Another 
plausible reason is that nphHOCl could be in situ generated in both mitochondria and lysosome of 
LPS/PMA-stimulated macrophage cells. This is because the respiratory burst induced by LPS and PMA 
in mitochondria produces higher amount of H2O2,
5,69,74
 which can easily transfer to other organelles like 
the lysosome due to its good plasma membrane permeability.70 Meanwhile, it is reported that MPO is 
located not only in lysosome but also in mitochondria of macrophage cells.50,51 Therefore, it is assumed 
that H2O2 may work with MPO to produce nphHOCl in both mitochondria and lysosome.  
 
Two-photon tissue imaging of HOCl in inflamed mouse model. To examine whether nphHOCl can 
be in vivo detected in mitochondria and lysosome of macrophage cells in inflamed mouse model, 200 
μL LPS (1 mg/mL) was subcutaneously injected into right rear paws of mouse to cause inflammation 
(Figure 7A). After 1 day, MITO-TP and LYSO-TP were intravenously injected and the paw skin was 
sectioned 1 hour later. As shown in Figure 7B, strong fluorescence from both MITO-TP and LYSO-
TP in LPS-stimulated macrophage cells was observed in inflammation tissues (shown in green color), 
which was further confirmed by immune-staining histological sections with macrophage marker 
CD11b (shown in red color). However, the signals from both probes and macrophage marker remained 




Figure 7. Detection of LPS-dependent HOCl generation in inflammation tissues via LYSO-TP and 
MITO-TP. A) 200 μL LPS (1 mg/mL) was subcutaneously (i.h.) injected into right rear paws of 
mouse to cause inflammation. After 1 day, 200 µL of 1 mM MITO-TP (or LYSO-TP) was intrave-
nously (i.v.) injected and the paw skin was sectioned 1 hour later. B) Fluorescence images of probes 
and CD11b in the inflamed tissue. Probe fluorescence: green, antibody CD11b: red. Arrows indicates 
the merged parts of HOCl sensitive probes and CD11b. C) 3D volume-rendered image shows the dis-
tribution of macrophages within the inflamed and normal tissues. (+): inflammation tissues; (-): normal 
tissues; Scale bar: 30 μm.     
 
Besides, the fluorescence from MITO-TP and LYSO-TP was collected at different depth in inflamed 
tissues and reconstructed in 3D box to describe the spatial distribution of LPS-stimulated macrophage 
cells (Figure 7C). Taken together, MITO-TP and LYSO-TP was successfully applied to stain the mac-
rophage cells in inflamed mouse model through intravenous injection. Importantly, it is indicated that 
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much higher concentration of nphHOCl in both mitochondria and lysosome of macrophage cells could 
be detected during inflammation.   
Conclusion 
In summary, we have developed the first two-photon fluorescent “turn-on” HOCl probe (TP-HOCl 
1) and its mitochondria (MITO-TP) and lysosome (LYSO-TP) targetable derivatives to image HOCl 
among corresponding organelles. Because of the unique oxidation de-protection mechanism, these 
probes show not only fast response (within seconds) and good sensitivity (< 20 nM) to HOCl but also 
high selectivity over other ROS and bio-molecules. Cell imaging experiments indicate that probes 
MITO-TP and LYSO-TP display good cell penetration and localize in mitochondria and lysosome of 
living cells respectively. Furthermore, it was indicated that HOCl may be detected in both mitochondria 
and lysosome of LPS/PMA-stimulated macrophage cells. In particular, two-photon imaging shows that 
much larger amount of HOCl can be detected in both lysosome and mitochondria of macrophage cells 
during inflammation condition in murine model. Therefore, due to the advantages of these probes, they 
can not only help elucidate the distribution of sub-cellular HOCl, but also serve as excellent tools to ex-
ploit potential functions of HOCl at sub-cellular and tissue levels.    
Synthesis, additional spectroscopic and imaging data, Gaussian calculation results, and MTT results. This ma-
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1. Supplemental Figures and Tables 
Table S1. Properties of respresentive fluorescent HOCl probes 
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27 30 min Na2B4O7/NaOH buffer 
(pH 12);             pH 




 thioether -- within 
seconds 
PBS ( pH 7.4, 0.10 to 
20% DMF);         pH 
range: 4.0–9.0 




thioether -- within 
seconds 
PBS (pH 7.4); 
pH range: 4.0-9.0 








300 within 5 
min 
PBS (pH 7.4, 10% 
DMSO);            pH 
range: 3.0-8.0 
Endogenous / neutro-






-- -- KH2PO4 buffer/CH3CN 
(pH 5.5, 99:1); 
-- 
Endogenous / neutro-
phils and intestinal epi-
thelia 




200 within 1 
min 
KH2PO4 buffer (pH 7.4); 
pH range: ≥  5.5 
Endogenous / intestinal 






thioether 53.5 -- PBS (pH 7.4); 
pH range: 4.5–10.5 







ether 33 within 10 
min 
borate buffer (pH 7.4); 
pH range: 3.0–10.0 






PBS/DMF (pH 7.4, 1:1); 
pH range: 3.0–11.0 







-- -- PBS (pH 7.5) ;  
pH range: 5.0-8.0 







42 within 15 
min 
PBS (pH 7.4) 
-- 
-- 





18 within 15 
min 
PBS (pH 7.4); 








37 within 15 
min 








oxime -- within 
seconds 
PBS/DMF (pH 9.0, 1:4);               




oxime -- within 
seconds 
HEPES/DMSO (pH 7.05, 
1:9);                pH range: 
7.0–10.0 
Exogenous / HeLa cell 
Bodipy-OX14 502/529; 
~48-fold 
oxime 500 within 
seconds 
PBS/DMF (pH 7.2, 4:1) 
pH range: 4.0–9.0 







≈ 13 (1 
ppm) 
-- DMF/HEPES (pH 7.2, 4 : 
1) 




pyrrole 0.56 within 1 s PBS/EtOH (pH 7.4, 1:9);         
pH range: 4.0–9.0 




selenide 310 within 
dozens of 
seconds 
PBS buffer (pH 7.4); 
pH range: 4.0-10.0 




selenide 7.98 within 4 
minuties 
MPBS /CH3CN (pH7.4, 








selenide 10 within 
seconds 






selenide 18.5 within 
seconds 
CH3CN/H2O (pH 5.0, 
1:1);               pH range: 
2.5-8.5 
Exogenous / lysosome of 











(pH 5.0);            pH 
range: 4.5-8.0 
Exogenous / lysosome of 




thioether 17.9 within 
seconds 
PBS (pH 7.3) 
pH range: 4.0-10.0 
Endogenous / mitochon-
dria of RAW 264.7 cells 










DMF/PBS buffer (pH 
7.4, 3:7); 
pH range: 4.0-10.0 
Exogenous / mitochon-
dria of Raw 264.7 cells 







PBS (pH 7.4) 
pH range: 4.0-10.0 
Exogenous / mitochon-
dria of HeLa cells and 
nude mice 






PBS/EtOH (1:1, PH 7.4) 








PBS ( PH 7.4) 
-- 
Endogenous / mitochon-
dria of Raw 264.7 cells 







PBS ( PH 5.0) 
-- 
Endogenous / lysosome 
of Raw 264.7 cells and 
inflamed tissues 
a Absorption and emission wavelength. b The fluorescence enhanced factor or emission ratio changes before and after 
interaction with HOCl. c The recognition moieties that respond to HOCl. d The reported detection limit of correspond-
ing probes. e The reaction time for responding to HOCl. f The solution and pH used for spectrum measurement. g The 
worked pH range for responding to HOCl. h Imaging of endogenous or exogenous HOCl. i In recent years, some fluo-
rescent probes with high selectivity and sensitivity, fast response, and wide range of working pH have been developed 
for the detection of HOCl in biological system. The design strategies for developing HOCl probes are based on specific 
reactions between HOCl and recognition sites, which changes fluorescence intensity significantly before and after reac-
tion. Based on the reference, the recognition moieties include p-methoxyphenol10,11, dibenzoylhydrazine,1 oxime,12-15 
selenide,17-20 thiol (tetrahydrothiophene/thioether2-3,7,22, internal thioester4-6,21 and thiosemicarbazide9) and other 
groups.8,16 Most of the probes can respond to HOCl with good sensitivity (usually dozens of nM) in a very short reac-
tion time (usually from seconds to minutes). Some probes were successfully applied in real-time detection of endoge-
nous HOCl insides cells and a small number of probes were used to image HOCl in inflamed tissues of mice. Among 
these probes, several organelles (mitochondria22-24 and lysosome20-21) targetable probes have been reported since 2013. 
The endogenous mitochondrial HOCl was successfully detected by PZ–Py,22 which was developed by Wang’s group. 
However, the detection of endogenous HOCl in lysosome has not been reported in existing papers, even two lysosomal 
probes were developed. In addition, no report exists describing a TPM (two-photon microscopy) based probe for direct 
imaging of endogenous HOCl produced in both live cells and tissues. Therefore, considering greater tissue penetration 
depths, higher spatial resolution, and lower photo-toxicity of TPM, organelles targetable two-photon probes can be a 









Table S2. Photophysical parameters of fluorophores.  
Dye max OP (nm)a ɛ max SP (10
4cm-1mol-1)b  c 




1 356 1.26 0.40 750 82 
TP-HOCl 1 356 1.23 <0.001 750 n.d. f 
7 356 1.24 0.41 750 83 
MITO-TP 356 1.22 <0.001 750 n.d. f 
4 356 1.25 0.35 750 74 
LYTO-TP 356 1.23 <0.001 750 n.d. f 
8 356 1.24 <0.001 750 n.d. f 
9 356 1.27 0.38 750 79 
a Maximum one photon absorbance wavelength of fluorophores in MeOH. b The molar extinction coefficients at max. c 
Fluorescence quantum yield. d Maximum two photon-excitation wavelength. e The peak of two-photon-action cross-
section (GM: 10-50 cm4 s photon-1).  f n.d.: not determined. The two-photon emission intensity was too weak to measure 
the cross-section accurately. 
 
Figure S1. The frontier molecular orbitals (MOs) of TP-HOCl 1 (A) and compound 1 (B) involved in 
the vertical excitation (i.e. UV-vis absorption, the left columns) and emission (right columns) shown in 
solid line. Methanol (CPCM model) was employed as the solvent for the DFT calculations. The vertical 
excitation related calculations are based on the optimized ground state (S0 state), the emission related 
calculations were based on the optimized excited state (S1 state), at the B3LYP/6-31G (d)/level using 
























Figure S2. The emission spectra of three probes (5μM) after adding 50 μM HOCl. Excitation wave-




Figure S3. The linear fluorescence response of TP-HOCl 1 to the concentration of HOCl at the nano-
molar concentration range (0-200 nM).  
 




















y = 1.609 + 0.0967x
r = 0.991 
A B




















 TP-HOCl 1 
 TP-HOCl 1 + 10 Cl





Figure S4. TP-HOCl 1 can respond to HOCl within seconds at pH 5.5 (A), 7.4 (B) and 9.2 (B). Arrows 
indicate the addition of 25 μM HOCl.  
 
 
Figure S5. Fluorescence response of TP-HOCl 1 (5 μM) towards various ROS (50 μM for HOCl (8) 
and 250 μM for other ROS/RNS (1-7)) at pH 5.5 (A) and 7.8 (B). 1) H2O2; 2) •OH; 3) O2-; 4) NO•; 5) t-
BuOOH; 6) t-BuOO•; 7) ONOO-; 8) HOCl. 
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Figure S6. The fluorescence spectra of TP-HOCl 1 (5 μM) after adding HOCl (100 μM) and H2O2 (100 
and 500 μM) in EtOH (B) and PBS/MeOH (1 : 1) solution (C). D) TP-HOCl 1 kept stable in the pres-
ence of H2O2 (500 μM) in PBS (pH 5.0, 6.0, 7.0). 
 
Figure S7. Fluorescence intensity of TP-HOCl 1 (5 μM) before and after adding HOCl (●) or ONOO- 
(■) at different concentrations (0 to 100 μM).   
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Figure S8. A) The absorption spectra of TP-HOCl 1 and de-protected compound 1 in MeOH. B) The 
fluorescence spectra of TP-HOCl 1 before and after addition of HOCl in PBS buffer (pH 4 to 9), data 
acquired at 20 seconds after addition of HOCl (λex = 375 nm).  
 
Figure S9. Reversed-phase HPLC chromatograms with absorption (350 nm) detection. The * and ** 
indicate compound 1 and chlorinated fluorophore (compound 9), respectively. A) Reversed-phase 
HPLC chromatograms of 100 μM TP-HOCl 1. B) Reversed-phase HPLC chromatograms of 100 μM 
TP-HOCl 1 in the presence of 100 μM HOCl for 1 min. C) Reversed-phase HPLC chromatograms of 
100 μM probe TP-HOCl 1 in the presence of 200 μM HOCl for 1 min. D) Reversed-phase HPLC 
chromatograms of 50 μM compound 1. E) Reversed-phase HPLC chromatograms of 50 μM chlorinated 
fluorophore (compound 9).  
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Figure S10. 1H NMR, 13C NMR, HRMS and H-H COSY spectrum of compound 9. Assignments and 
proton connectivity of compound 9 were based on vicinal and long-distance J-coupling in COSY exper-
iments. All the connections between adjacent protons were observed. The peak at 8.325 ppm was 
assigned to Ha, which has a long distance J-coupling with Hc (δ = 8.023 (d, J = 1.5 Hz, 1H). The single 
peak at 8.018 ppm was assigned to Hb. The correlated proton resonances at 7.800 ppm and 7.115 ppm 
were assigned to Hd and He respectively.  
 


























Figure S11. A) Synthetic route toward intermediate 8. B) The purity and molecular mass of compound 
8 was confirmed by Liquid chromatography–mass spectrometry (LC-MS). C) The fluorescence en-
hancement of compound 8 responding to HOCl rather than H2O2 at 100 μM. Probe concentration: 10 
μM. Excitation wavelength: 375 nm. D) The fluorescence response of compound 8 to HOCl (15 nM – 
200 nM) in PBS/EtOH (1:1, pH 7.4), with the detection limit about 10.3 nM for HOCl. E) Fluorescence 
intensity of compound 8 and compound 8 in the presence of HOCl (200 nM) with time changes. 
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Figure S12. A) The fluorescence response of MITO-TP to HOCl (25 nM – 10 μM) in pH 7.4 PBS 
buffer (1% DMSO). B) The fluorescence respond of LYSO-TP to HOCl (50 nM - 10 μM) in pH 5.0 
PBS buffer (1% DMSO). Excitation wavelength: 375 nm.  
 
 
Figure S13. Cytotoxic effect of MITO-TP and LYSO-TP. HeLa cells were incubated with each con-
centration of probes for 12 h. Cell viability was assayed with MTT test. Results are expressed as mean ± 
standard deviation of 5 independent experiments. 
A B












































Figure S14. Intracellular localization of MITO-TP (A) and LYSO-TP (B) in HeLa cells. A) Images of 
HeLa cells pre-treated respectively with 10 μM MITO-TP for 20 min and subsequently 1 μM Lyso-
Tracker Red (or 1 μM red cell permeable DNA dye Vybrant® DyeCycle™ Ruby) for 10 min. Then 50 
μM HOCl was treated for another 5 min. B) Images of HeLa cells pre-treated respectively with 10 μM 
LYSO-TP for 20 min and subsequently 1 μM Mito-Tracker Red (or 1 μM red cell permeable DNA dye 
Vybrant® DyeCycle™ Ruby ) for 10 min. Then 50 μM HOCl was treated for another 5 min. Green: 
probe fluorescence; red: Mito-Tracker, Lyso-Tracker and Nucl- Tracker fluorescence (Vybrant® Dye-





MITO-TP Lyso. tracker Overlap Bright Field
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Figure S15. Intracellular distribution of MITO-TP and LYSO-TP in LPS/IFN-γ-stimulated macro-
phage cells. RAW 264.7 cells was pre-treated with LPS (120 ng/mL) / IFN-γ (20 ng/mL) for 24 h, then 
treated with 10 μM MITO-TP (or 10 μM LYSO-TP) for 20 min and subsequently 1 μM Lyso-Tracker 
Red (or 1 μM Mito-Tracker Red) for another 10 min. Green: probe fluorescence; red: Mito-Tracker and 
Lyso-Tracker fluorescence; yellow: merged signal. Scale bar: 10 μM. 
 
LYSO-TP Mito. tracker merge Bright Field




Figure S16. Fluorescent imaging of RAW cells incubated with compound 7 and 4 (precursor of MITO-
TP and LYSO-TP) for different times. A) Compound 7 (10 μM) was incubated with Raw cells for dif-
ferent times and washed by pH 7.4 PBS prior to image. B) Compound 4 (10 μM) was incubated with 
Raw cells for different times and washed by pH 7.4 PBS prior to image. C, D). Time course of fluores-
cent intensity ratio of RAW cells after incubation with compound 7 and 4. The intensities were normal-







Figure S17. Detection of endogenous HOCl in live RAW 264.7 macrophage cells via MITO-TP and 
LYSO-TP. A) Representative fluorescent images of macrophage cells. a, e) MITO-TP or LYSO-TP 
(10 μM) was incubated with macrophages cells for 30 min. b, f) Cells were stimulated with LPS (120 
ng/mL) / IFN-γ (20 ng/mL) for 24 h and then incubated with MITO-TP or LYSO-TP (10 μM) for 30 
min, washed by PBS buffer prior to imaging. c, g)  Cells were stimulated with LPS (120 ng/mL) / IFN-γ 
(20 ng/mL) for 24 h and then treated with 200 μM ABH for 1 h, subsequently incubated with MITO-
TP or LYSO-TP (10 μM) for 30 min, washed by PBS buffer prior to imaging. d, h) Cells were stimu-
lated with LPS (120 ng/mL) / IFN-γ (20 ng/mL) and ABH (200 μM) for 24 h, subsequently incubated 
with MITO-TP or LYSO-TP (10 μM) for 30 min, washed by PBS buffer prior to imaging. B, C) 
Quantiﬁcation of the ﬂuorescence signals from a-h. Data were normalized to the fluorescence intensity 





Figure S18. Normal tissue imaging with LYSO-TP (or MITO-TP) and antibody CD11b. Probe fluo-
rescence was shown in green, antibody CD11b fluorescence was shown in red. Scale bar: 30 μM.   
 
 
2. Materials and General Experimental Methods 
All chemical reagents for the probe synthesis were obtained from Sigma Aldrich, Alfa Aesar, MERCK 
or Acros, and used without further purification unless otherwise specified. Column chromatography was 
carried out on Merck Silica Gel 60 (0.040-0.064 mm, 230400 mesh).  Synthetic reactions and analyti-
cal characterization were monitored by HPLC-MS (Agilient-1200 series) with a DAD detector and a 
single quadrupole mass spectrometer (6130 series) with an ESI probe. NMR spectra (1H-300 or 500 
MHz and 13C-75 or 125 MHz) were recorded on Bruker Avance 300 or 500 NMR spectrometers. The 
high resolution electron spray ionization (HR-ESI) mass spectra were obtained on a Bruker micrOTO-
FQII. Spectroscopic and quantum yield data were measured on spectroscopic measurements, performed 
on a fluorometer and UV/VIS instrument, Spectra Max M2 by Molecular Device (The slit width: 1 nm). 
pH Value was determined by a Mettler Toledo S220 SEVENCOMPACT pH meter (Columbus, OH). 
Fluorescence microscopic images were obtained from a ﬂuorescence Ti microscope (Nikon) inverted 
microscope with epifluorescence and phase contrast optics using 20× objective lenses.  The green fluo-
rescence was collected by using an Ex 370 nm/40, Em 500 nm/40 ﬁlter. Two-Photon tissue images were 
acquired in Leica TCS SP5 X Confocal Microscope.  
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3. Synthesis and Characterization 
Preparation of TP-HOCl 1, TP-HOCl 2 and TP-HOCl 3. Compound 1 (10 mg, 0.05 mmol), me-
thanesulfonic acid (20 μL) and 2-mercaptoethanol (5.2 mg, 0.06 mmol) (or Ethanedithiol (4.7 mg, 0.06 
mmol) or hydroxylamine (4.2 mg, 0.06 mmol)) were mixed in 3 mL dichloromethane solution and re-
fluxed for 3 h under nitrogen protection.  The reaction was monitored by HPLC-MS and a product with 
reduced polarity was observed. Then the mixture was purified by preparative TLC with a solvent system 
(CH2Cl2: hexane = 1:1 ). Light yellow solid product was obtained.  
TP-HOCl 1. Yield: 7.7 mg (59.6%). 1H NMR (300 MHz, CD2Cl2) δ 7.82 (d, J = 1.7 Hz, 1H), 7.66 (d, J 
= 3.1 Hz, 1H), 7.63 (d, J = 2.9 Hz, 1H), 7.50 (dd, J = 8.6, 1.9 Hz, 1H), 6.93 (dd, J = 8.8, 2.4 Hz, 1H), 
6.82 (d, J = 2.2 Hz, 1H), 4.40 (ddd, J = 9.1, 6.3, 5.0 Hz, 1H), 4.21 – 4.09 (m, 1H), 3.28 (dt, J = 10.0, 6.6 
Hz, 1H), 3.20 – 3.09 (m, 1H), 2.95 (s, 3H), 2.00 (s, 3H). 13C NMR (75 MHz, CD2Cl2) δ 147.21, 139.75, 
134.38, 128.86, 126.51, 125.78, 124.28, 122.76, 118.02, 103.21, 95.64, 70.73, 34.39, 31.74, 30.44. ESI-
MS C15H18NOS
+ [M + H+], found 260.1109, calculated 260.1104. 
TP-HOCl 2. Yield: 7.1 mg (51.4 %). 1H NMR (300 MHz, CD2Cl2) δ 8.00 (d, J = 2.0 Hz, 1H), 7.85 – 
7.73 (m, 1H), 7.64 (dd, J = 8.7, 5.2 Hz, 2H), 6.93 (dd, J = 8.8, 2.4 Hz, 1H), 6.81 (d, J = 2.2 Hz, 1H), 
3.63 – 3.37 (m, 4H), 2.96 (d, J = 4.6 Hz, 3H), 2.28 (d, J = 4.5 Hz, 3H). 13C NMR (75 MHz, CD2Cl2) δ 
147.45, 138.43, 134.19, 128.89, 126.44, 126.17, 125.64, 124.46, 117.92, 103.12, 68.47, 40.50, 33.33, 
30.41. ESI-MS: C15H18NS2
+ [M+H+], found 276.0882, calculated 276.0875. 
Preparation of compound 3. Compound 3 was synthesized according the literature procedure.25  
Preparation of compound 4.  Compound 3 (186.1 mg, 1.0 mmol), 2-morpholinoethanamine (65.1 mg, 
5.0 mmol) and Na2S2O5 (380.2 mg, 2.0 mmol) were dissolved in 4 mL water and stirred at 160 ˚C under 
microwave (80 mW) for 5 h. After reaction, the solvent was removed under vacuum. The solid product 
was purified by column chromatography using EtOAc : hexane (1 : 1) solution. Yield: 172 mg, 57.7%. 
1H NMR (300 MHz, CDCl3) δ 8.34 (s, 1H), 7.96 (dd, J = 8.6, 1.6 Hz, 1H), 7.77 (d, J = 8.8 Hz, 1H), 7.65 
(d, J = 8.7 Hz, 1H), 7.01 (dd, J = 8.8, 2.1 Hz, 1H), 6.81 (d, J = 2.0 Hz, 1H), 3.86 – 3.74 (m, 4H), 3.35 (t, 
J = 5.8 Hz, 2H), 2.80 – 2.73 (m, 2H), 2.70 (s, 3H), 2.58 (d, J = 4.1 Hz, 4H). 13C NMR (75 MHz, CDCl3) 
δ 197.94, 148.38, 138.19, 130.97, 130.91, 130.53, 126.08, 126.05, 124.92, 118.82, 103.72, 66.99, 56.85, 
53.39, 39.50, 26.57. ESI-MS: C18H23N2O2
+ [M+H+], found 299.1765, calculated 299.1754.   
  
41 
Preparation of compound 5.  The mixture of compound 3 (71.0 mg, 0.35 mmol), propane-1,3-diamine 
(77.5 mg, 1.05 mmol) and Na2S2O5 (136.1 mg, 0.70 mmol)  in 4.0 mL water and was stirred at 160 ˚C 
under microwave (80 mW) for 5 h. Then the solvent was removed under vacuum and the solid product 
was purified by preparative HPLC (method: 0 min, 5 % CH3CN 7 min, 35% CH3CN; 9 min 95% 
CH3CN; 10 min 5% CH3CN). The water and acetonitrite mixture was removed under vacuum.  Yield: 
49.7 mg (53.8%). 1H NMR (500 MHz, DMSO) δ 8.46 (s, 1H), 8.35 (s, 1H), 7.78 (t, J = 9.1 Hz, 2H), 
7.58 (d, J = 8.6 Hz, 1H), 7.03 (d, J = 8.8 Hz, 1H), 6.76 (s, 1H), 3.23 (t, J = 6.6 Hz, 2H), 2.90 (t, J = 7.2 
Hz, 2H), 2.58 (s, 3H), 1.96 – 1.77 (m, 2H).
 
13C NMR (75 MHz, DMSO) δ 198.21, 149.69, 138.93, 
131.30, 131.25, 130.82, 126.23, 126.15, 124.88, 119.53, 102.93, 37.93, 27.29, 26.40. ESI-MS: 
C15H19N2O
+ [M+H+], found 243.1496, calculated 243.1492.   
Preparation of compound 7. Compound 5 (121.2 mg, 0.50 mmol), Triethylamine (5 μL) and 2-
bromoacetyl chloride (86.4 mg, 0.55 mmol) were dissolved in 6 mL dichloromethane and stirred at 
room temperature for 50 min. The compound 6 was obtained and used to next step without purification. 
Then 393 mg triphenylphosphine (1.5 mmol) was added into the mixture and stirred at room tempera-
ture for 16 h. The light yellow solid product 7 was obtained after purification by column chromatog-
raphy with CH2Cl2 / MeOH (100 : 8) mixture solution. Yield: 223.4 mg (82%).  
1H NMR (300 MHz, 
CDCl3) δ 9.70 (s, 1H), 8.22 (s, 1H), 7.85 (dd, J = 8.7, 1.8 Hz, 1H), 7.80 – 7.67 (m, 9H), 7.63 – 7.55 (m, 
7H), 7.53 (d, J = 8.8 Hz, 1H), 7.03 (dd, J = 8.8, 2.2 Hz, 1H), 6.65 (d, J = 2.0 Hz, 1H), 4.89 (d, J = 14.2 
Hz, 2H), 3.23 (dd, J = 11.9, 5.9 Hz, 2H), 3.15 (t, J = 6.2 Hz, 2H), 2.62 (s, 3H), 1.74 (dt, J = 12.4, 6.3 
Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 197.78, 162.35, 162.29, 148.51, 138.13, 134.97, 134.93, 133.97, 
133.83, 130.51, 130.39, 130.19, 130.16, 129.98, 125.65, 125.42, 124.45, 119.06, 118.81, 117.64, 
102.70, 40.30, 37.42, 27.06, 26.33. ESI-MS: C35H34N2O2P
+ [M+], found 545.2360, calculated 545.2352.   
Preparation of MITO-TP and LYSO-TP. Compound 4 (29.8 mg, 0.1 mmol) (or compound 7 (54.5 
mg, 0.1 mmole)), 2-mercaptoethanol (10.4 mg, 0.12 mmol) and methanesulfonic acid (20 µL) were 
mixed in 4 mL dichloromethane solution and refluxed for 3 h under nitrogen protection.  The reaction 
was monitored by HPLC-MS and the product with reduced polarity was observed.  Then the mixture 
was purified by preparative TLC with a solvent system (CH2Cl2 / Methanol = 100 : 8 ). Light yellow 
product was obtained. 
LYSO-TP. Yield: 21.8 mg (61.1%).  1H NMR (300 MHz, CDCl3) δ 7.79 (d, J = 1.7 Hz, 1H), 7.62 (d, J 
= 9.0 Hz, 1H), 7.57 (d, J = 8.5 Hz, 1H), 7.47 (dd, J = 8.6, 1.9 Hz, 1H), 6.94 (dd, J = 8.7, 2.3 Hz, 1H), 
6.78 (d, J = 2.1 Hz, 1H), 4.38 (ddd, J = 9.1, 6.4, 4.7 Hz, 1H), 4.09 (ddd, J = 9.1, 7.3, 6.2 Hz, 1H), 3.81 – 
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3.71 (m, 4H), 3.33 – 3.27 (m, 2H), 3.27 – 3.20 (m, 1H), 3.14 – 3.06 (m, 1H), 2.77 – 2.68 (m, 2H), 2.59 – 
2.49 (m, 4H), 1.98 (s, 3H).
 
13C NMR (75 MHz, CDCl3) δ 146.17, 139.73, 134.35, 129.15, 126.67, 
126.01, 124.31, 122.97, 118.30, 104.15, 95.98, 70.60, 66.75, 56.89, 53.25, 39.76, 34.41, 32.07. ESI-MS: 
C20H27N2O2S
+ [M+H+], found 359.1800, calculated 359.1788.   
MITO-TP. Yield: 39.4 mg (65.2%).  1H NMR (300 MHz, CDCl3) δ 9.89 (t, J = 5.5 Hz, 1H), 7.81 – 
7.66 (m, 10H), 7.58 (ddd, J = 10.8, 5.4, 2.5 Hz, 7H), 7.51 (s, 1H), 7.41 (dd, J = 8.6, 1.9 Hz, 1H), 6.95 
(dd, J = 8.8, 2.2 Hz, 1H), 6.68 (d, J = 2.1 Hz, 1H), 4.91 (d, J = 14.2 Hz, 2H), 4.35 (ddd, J = 9.1, 6.4, 4.7 
Hz, 1H), 4.06 (ddd, J = 9.1, 7.2, 6.2 Hz, 1H), 3.17 – 3.27 (m, 3H), 3.15 – 3.01 (m, 3H), 1.95 (d, J = 6.8 
Hz, 3H), 1.79 – 1.68 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 162.43, 162.36, 146.16, 139.13, 134.92, 
134.88, 134.43, 133.99, 133.85, 130.14, 129.97, 128.92, 126.29, 125.89, 124.04, 122.94, 118.92, 
118.62, 117.75, 103.62, 96.04, 77.42, 77.00, 76.57, 70.55, 41.35, 40.75, 37.50, 34.36, 32.03, 27.36. ESI-
MS: C37H38N2O2PS
+ [M+], found 605.2393, calculated 605.2386.   
Preparation of compound 8. Compound 1 (10 mg, 0.05 mmol), 2-mercaptoethanol (5.2 mg, 0.06 
mmol) and methanesulfonic acid (20 μL) were mixed in 3 mL dichloromethane (CH2Cl2) solution and 
refluxed for 8 h in air. The solvent was removed under vacuum and the mixture was purified by prepara-
tive TLC with a solvent system (CH2Cl2 / hexane = 1 : 1). Light yellow product was obtained. Yield: 6.6 
mg, 48.2% 1H NMR (300 MHz, CDCl3) δ 7.96 (t, J = 10.8 Hz, 1H), 7.75 (dd, J = 8.7, 2.1 Hz, 1H), 7.60 
(dd, J = 8.7, 3.4 Hz, 2H), 6.88 (dd, J = 8.8, 2.4 Hz, 1H), 6.77 (d, J = 2.2 Hz, 1H), 3.55 – 3.37 (m, 4H), 
2.93 (s, 3H), 2.23 (d, J = 5.2 Hz, 3H).
 
13C NMR (75 MHz, CDCl3) δ 147.25, 138.52, 134.20, 129.09, 
126.33, 125.95, 124.58, 117.92, 103.57, 68.80, 40.33, 33.40, 30.71. ESI-MS: C15H18NO2S
+ [M + H+], 
found 276.1058, calculated 276.1053. 
Preparation of compound 9. 20 mg (0.1 mmole) compound 1 was mixed with 100 μL NaOCl (4%, 
0.11 mmol) in MeOH / H2O (1 : 1) solution and stirred at room temperature for 2 h. After reaction, 20 
mL ice water was added and extracted with dichloromethane (3 x 40 mL). The organic layer was dried 
by anhydrous Na2SO4 and yellow solid product was obtained, which was purified by preparative TLC 
with dichloromethane and hexane (2 : 1) mixture solvent. Yield: 19.3 mg, 83%.  1H NMR (500 MHz, 
CD2Cl2) δ 8.325 (s, 1H), 8.023 (d, J = 1.5 Hz, 1H), 8.018 (s, 1H), 7.800 (d, J = 8.9 Hz, 1H), 7.115 (d, J 
= 8.9 Hz, 1H), 3.07 (s, 3H), 2.68 (s, 3H).
 
13C NMR (125 MHz, CDCl3) δ 197.45, 144.72, 133.79, 
130.86, 130.67, 129.83, 125.86, 125.58, 122.19, 113.45, 110.63, 30.35, 26.42. ESI-MS: C13H13ClNO
+ 
[M + H+], found 234.0680, calculated 234.0680.   
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4. Photo-spectroscopic Studies 
Measurement of photo-physical properties.  All absorption and emission spectra were recorded on a 
Spectra Max M2 by Molecular Device at 25 C.  The slit width of both excitation and emission is 1 nm. 
Stock solutions of the probes in DMSO (10 mM) were used to prepare the working solutions in PBS 
(0.1M, pH 7.4) / EtOH (1 : 1) or PBS (1% DMSO, pH 7.4 or 5.0) buffer solution with a final concentra-
tion of 5.0 µM.  Absorbance and emission spectra were recorded immediately after addition of different 
concentration of HOCl.  
Measurements of two-photon fluorescence spectra. Two-photon fluorescence spectra were measured 
by using a Ti: sapphire oscillator (Avesta Ti-Sapphire TiF-100M) as the excitation source, which gives 
output of 750 nm laser pulses with pulse duration of 80 fs and repetition rate of 84.5 MHz. The laser 
beam was filtered through a 750/10 nm bandpass filter (Semrock LD01-785/10-25) to reduce their inter-
ference to the measured emission. The sample was excited by a tightly focused laser beam with fluores-
cence collected at a 90° angle to minimize the scattering. The emission signal was directed into a CCD 
(Princeton Instruments, Pixis 100B) coupled monochromator (Acton, Spectra Pro 2300i) with an optical 
fiber.  
In vitro Myeloperoxidase (MPO)/H2O2/Cl- system. 1 U/mL MPO (Sigma) was dissolved in PBS 
(pH=7.4, 37 ˚C) and the probe TP-HOCl 1 (5 ìM) was further added into the solution. After addition of 
H2O2 (20 μM), the fluorescence intensities were recorded immediately in a Spectra Max M2 micro-plate 
reader. Besides, in inhibition experiment, 10 μM 4-aminobenzoic acid hydrazide (ABH) was added to 
inhibit MPO before addition of H2O2. Furthermore, ABH (4-Aminobenzoic acid hydrazide, 10 μM) or 
Cys (cysteine, 200 μM) was added at 1 and 2 min respectively. 
5. Analytical HPLC analysis 
To examine the sensing mechanism of TP-HOCl 1 responding to HOCl, high pressure liquid chroma-
tography (HPLC) – Mass spectra (MS) were conducted after the incubation of HOCl at different con-
centration. The signals were recorded at 350 nm and 500 nm as a function of retention time. H2O (eluent 
A) / acetonitrile (eluent B) with a linear gradient elution profile: 0 min, 95% A; 1 min, 95% A; 7 min, 5% 
A; 8.5 min, 5% A; 9 min, 95% A; 10 min, 95% A was used as the mobile phase. The temperature of the 




6. In Vitro Fluorescence Microscopic Studies 
Cell culture. Murine RAW 264.7 cells lines and HeLa cells lines (American Type Culture collection) 
were grown as mono-layers in 75-cm2 flasks containing DMEM (BSF) supplemented with 10% FBS 
(PAA), 1% penicillin streptomycin glutamine (GIBCO) at 37ºC in a humidified incubator of 5% CO2. 
Cells were carefully harvested and split when they reached 80% confluence to maintain exponential 
growth.  
Fluorescence microscopic imaging.  To avoid the artifacts that occur during fixation procedures, all 
the experiments were conducted in live cells. The cell experiment can be divided into four groups. The 
first group is that RAW 264.7 macrophage cells were incubated with 15 μM MITO-TP (or LYSO-TP) 
for 20 min. Then the cells were washed by PBS buffer before imaging. In the second group, RAW 264.7 
macrophage cells were incubated with 15 μM MITO-TP (or LYSO-TP) for 20 min, washed by PBS 
buffer and subsequently incubated with Lipopolysaccharide (LPS, 1 μg/mL) and Phorbol Myristate 
Acetate (PMA, 1 μg/mL) for 1 h prior to imaging. In the third and fourth the group RAW 264.7 macro-
phage cells were incubated with 15 μM MITO-TP (or LYSO-TP) for 20 min, washed by PBS buffer 
and subsequently incubated with Lipopolysaccharide (LPS, 1 μg/mL) / Phorbol Myristate Acetate 
(PMA, 1 μg/mL) and 4-aminobenzoic acid hydrazide (ABH, 200 μM) or N-acetylcysteine (NAC, 2 mM) 
respectively for 1 h prior to imaging. 
Determining the subcellular location of probes.  Live RAW 264.7 macrophage cells cultured in 35-
mm glass bottom culture dishes were incubated with LPS (120 ng/mL) and IFN –γ (20 ng/mL) for 24 h 
and 10 µM probes (MITO-TP and LYSO-TP) was further added. After 20 min treatment at 37 ºC, Mi-
toTracker (1.0 µM) and LysoTracker (1.0 µM) were added for another 10 min. Then the cells were 
washed by PBS prior to imaging. For further confirming the intracellular co-localization, HeLa cells 
were used to co-localize with trackers. The cells were treated with probes (10 µM) for 20 min and sub-
sequently with Trackers for 10 min, then with 50 µM HOCl for another 5 min. Then the cells were 
washed by PBS prior to imaging.  
Cell cytotoxicity in MTT assay. Cells were plated in 96-well flat-bottomed plates at 1×105 cells per 
well and allowed to grow 12 h prior to exposure to MITO-TP and LYSO-TP. Then the MTT reagent 
was added for 4 h at 37 oC and DMSO (100 μL/well) was further incubated with cells for 15 min after 
removing the medium. The absorbance at 570 nm and 690 nm (background signal) was recorded in a 
Spectra Max M2 microplate reader. The following formula was used to calculate the viability of cell 
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growth: Cell viability (%) = (mean of A value of treatment group / mean of A value of control) × 100. 
7. Two-photon Tissue Imaging Studies 
LPS-induced tissue inflammation. After anesthesia, 100 µL of 1 mg/mL LPS (Sigma) was injected on 
right paws of mice (6-8 week, C57BL6/J).  After 1 day, MITO-TP and LYSO-TP (200 µL, 1 mM) 
were injected through tail vein. After 1 h, the skin of the inflamed (right paw) and normal (left paw) tis-
sues were harvested and embedded in tissue-freezing medium (Triangle Biomedical Sciences), frozen 
and consecutively cryo-sectioned into 10 µm or 300 µm segments.  
Immunohistofluorescence. The 10 µm segments were carefully rinsed with PBS and fixed with 4% 
paraformaldehyde for 20 min at room temperature. Then the tissues were treated with 1% bovine serum 
albumin in PBS for 1 h. For confirmation of HOCl probes stain pattern, rat anti mouse CD11b antibody 
(Abcam, dilution factor 1:300) was applied and was visualized by cy5-conjugated goat anti rat second-
ary antibody (Life TechnologiesTM, dilution factor 1:300).  All imagings were taken by Leica TCS SPS 
X two photon microscope. The excitation wavelength is 750 nm and the collection wavelength range is 
from 450-520 nm. For the detection of cy5, the excitation wavelength is 630 nm and the collection 
wavelength range is from 650-670 nm. 
Two-photon inflamed tissue imaging. The 300 µm segments were carefully rinsed with PBS and cov-
ered with coverslip. Leica TCS SPS X microscope was used to take two photon imaging. The excitation 
wavelength is 750 nm and the collection wavelength range is from 450-520 nm. 3D construction was 















































1. Chen, X.; Wang, X.; Wang, S.; Shi, W.; Wang, K.; Ma, H. Chem. Eur. J. 2008, 14, 4719. 
2.  Kenmoku, S.; Urano, Y.; Kojima, H.; Nagano, T . J. Am. Chem. Soc.  2007, 129, 7313. 
3. Koide, Y.; Urano, Y.; Hanaoka, K.; Terai, T.; Nagano, T. J. Am. Chem. Soc. 2011, 133, 5680. 
4. Zhan, X.-Q.; Yan, J.-H.; Su, J.-H.; Wang, Y.-C.; He, J.; Wang, S.-Y.; Zheng, H.; Xu, J.-G. Sensor. Actuat. B: Chem. 
2010, 150, 774. 
5. Chen, X.; Lee, K. A.; Ha, E. M.; Lee, K. M.; Seo, Y. Y.; Choi, H. K.; Kim, H. N.; Kim, M. J.; Cho, C. S.; Lee, S. Y.; 
Lee, W. J.; Yoon, J. Chem. Commun. 2011, 47, 4373. 
6. Xu, Q.; Lee, K. A.; Lee, S.; Lee, K. M.; Lee, W. J.; Yoon, J. J. Am. Chem. Soc. 2013, 135, 9944. 
7. Zhang, R.; Ye, Z.; Song, B.; Dai, Z.; An, X.; Yuan, J. Inorg. Chem. 2013, 52, 10325. 
8. Ye, Z.; Zhang, R.; Song, B.; Dai, Z.; Jin, D.; Goldys, E. M.; Yuan, J. Dalton Trans. 2014, 43, 8414. 
9. Yuan, L.; Lin, W.; Xie, Y.; Chen, B.; Song, J. Chem. Eur. J. 2012, 18, 2700. 
10. Sun, Z. N.; Liu, F. Q.; Chen, Y.; Tam, P. K.; Yang, D. Org. Lett. 2008, 10, 2171. 
11. Hu, J. J.; Wong, N. K.; Gu, Q.; Bai, X.; Ye, S.; Yang, D. Org. Lett. 2014, 16, 3544. 
12. Lin, W.; Long, L.; Chen, B.; Tan, W. Chem. Eur. J. 2009, 15, 2305. 
  
56 
13. Cheng, X.; Jia, H.; Long, T.; Feng, J.; Qin, J.; Li, Z. Chem. Commun. 2011, 47, 11978. 
14. Emrullahoglu, M.; Ucuncu, M.; Karakus, E. Chem. Commun. 2013, 49, 7836. 
15. Zhao, N.; Wu, Y. H.; Wang, R. M.; Shi, L. X.; Chen, Z. N. Analyst 2011, 136, 2277. 
16. Zhu, H.; Fan, J.; Wang, J.; Mu, H.; Peng, X. J. Am. Chem. Soc. 2014, 136, 12820. 
17. Cheng, G.; Fan, J.; Sun, W.; Cao, J.; Hu, C.; Peng, X. Chem. Commun. 2014, 50, 1018. 
18. Liu, S. R.; Wu, S. P. Org. Lett. 2013, 15, 878. 
19. Li, G.; Zhu, D.; Liu, Q.; Xue, L.; Jiang, H. Org. Lett. 2013, 15, 2002. 
20. Qu, Z.; Ding, J.; Zhao, M.; Li, P. J. Photoch. Photobio. A 2015, 299, 1. 
21. Wu, X. J.; Li, Z.; Yang, L.; Han, J. H.; Han, S. F. Chem. Sci. 2013, 4, 460. 
22. Xiao, H.; Xin, K.; Dou, H.; Yin, G.; Quan, Y.; Wang, R. Chem. Commun. 2015, 51, 1442. 
23. Li, G.; Lin, Q.; Ji, L.; Chao, H. J. Mater. Chem. B 2014, 2, 7918. 
24. Hou, J.-T.; Wu, M.-Y.; Li, K.; Yang, J.; Yu, K.-K.; Xie, Y.-M.; Yu, X.-Q. Chem. Commun. 2014, 50, 8640. 
25. This work. 
 
 
